Fazel Darbandi, Siavash
Nelson, Andrew D.
Pai, Emily Ling-lin
Bender, Kevin J.
Rubenstein, John L. R.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NINDS R01 NS34661)
National Institutes of Health (R01 NS099099)
National Institutes of Health (NIH R01 MH125978)
National Institutes of Health (NIH F32 MH125536)
Simons Foundation (630332)
Article History
Received: 6 August 2021
Accepted: 25 January 2022
First Online: 5 February 2022
Declarations
:
: All procedures and animal care were approved and performed in accordance with the University of California San Francisco Laboratory Animal Research Center (LARC) guidelines.
: All contributing authors have read and agreed to submit this manuscript for publication.
: J.L.R.R. is the cofounder, stockholder, and currently on the scientific board of <i>Neurona</i>, a company studying the potential therapeutic use of interneuron transplantation. The other authors declare that they have no competing interests.